| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2024―Sep―01 |
Indomethacin inhibits human seasonal coronaviruses at late stages of viral replication in lung cells: effect on virus-induced COX-2 expression |
Caterina Tramontozzi, Anna Riccio, Silvia Pauciullo, Simone La Frazia, Antonio Rossi, M. Gabriella Santoro |
| 2 |
[GO] |
2024―Jun―12 |
Vaccination against COVID-19 among Healthcare Workers as a Cocoon Strategy for People Living with HIV |
Agata Skrzat-Klapaczyńska, Justyna Kowalska, Filip Fijołek, Marcin Paciorek, Carlo Bieńkowski, Dominika Krogulec, Andrzej Horban |
| 3 |
[GO] |
2023―Mai―26 |
Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 helicase inhibitors: A systematic review of in vitro studies |
Nimer Mehyar |
| 4 |
[GO] |
2023―Mrz―10 |
The poliovirus reemergence: Did concentrated efforts against COVID-19 open the door? |
Nour Shaheen, Abdelrahman Mohamed, Abdelraouf Ramadan, Abdulqadir J. Nashwan |
| 5 |
[GO] |
2022―Dez―20 |
PP 1.37 - 00186 Investigating Short-Term Effects of COVID-19 mRNA Vaccination on Plasma Viremia and Intact HIV Reservoir Size in Individuals Receiving Antiretroviral Therapy (ART) |
M.C. Duncan, F.H. Omondi, N.N. Kinloch, H.R. Lapointe, S. Speckmaier, N. Moran-Garcia, et al. (+6) C.F. Lowe, M.G. Romney, T. Lawson, M. Harris, M.A. Brockman, Z.L. Brumme |
| 6 |
[GO] |
2022―Dez―20 |
PP 7.4 - 00016 Acquisition of SARS-CoV-2 infection during an HIV cure study with an ATI period |
I. Mcgowan, L. Bailon, S. Devi, C. Brander, J.R. Arribas |
| 7 |
[GO] |
2022―Dez―20 |
PP 4.19 - 00021 Impact of SARS-COV-2-Mediated CD4 T Cell Activation HIV DNA Persistence In Vivo |
T.-M. Deveau, M. Peluso, A. Buck, N. Kumar, T. Henrich |
| 8 |
[GO] |
2022―Dez―13 |
Evolution of anti-SARS-CoV-2 spike protein titers after two-dose COVID-19 vaccination among people living with HIV |
Wang-Da Liu, Man Wai Pang, Jann-Tay Wang, Hsin-Yun Sun, Yu-Shan Huang, Kuan-Yin Lin, et al. (+19) Un-In Wu, Guei-Chi Li, Wen-Chun Liu, Yi-Ching Su, Pu-Chi He, Chia-Yi Lin, Chih-Yu Yeh, Yu-Chen Cheng, Yi Yao, Yi-Ting Chen, Pei-Ying Wu, Ling-Ya Chen, Yu-Zhen Luo, Hsi-Yen Chang, Wang-Huei Sheng, Szu-Min Hsieh, Sui-Yuan Chang, Chien-Ching Hung, Shan-Chwen Chang |
| 9 |
[GO] |
2022―Dez―09 |
Identification of a pharmacological approach to reduce ACE2 expression and development of an in vitro COVID-19 viral entry model |
Yukinori Endo, Brady T. Hickerson, Natalia A. Ilyushina, Nishant Mohan, Hanjing Peng, Kazuyo Takeda, et al. (+2) Raymond P. Donnelly, Wen Jin Wu |
| 10 |
[GO] |
2022―Dez―09 |
Host-directed therapy with 2-Deoxy-D-glucose inhibits human rhinoviruses, endemic coronaviruses, and SARS-CoV-2 |
Laxmikant Wali, Michael Karbiener, Scharon Chou, Vitalii Kovtunyk, Adam Adonyi, Irene Gösler, et al. (+7) Ximena Contreras, Delyana Stoeva, Dieter Blaas, Johannes Stöckl, Thomas R. Kreil, Guido A. Gualdoni, Anna-Dorothea Gorki |
| 11 |
[GO] |
2022―Sep―17 |
Langya virus outbreak in China, 2022: Are we on the verge of welcoming a new pandemic? |
Shehroze Tabassum, Aroma Naeem, Syeda Tayyaba Rehan, Abdulqadir J. Nashwan |
| 12 |
[GO] |
2021―Sep―16 |
Recent advances in SARS-CoV-2 Spike protein and RBD mutations comparison between new variants Alpha (B.1.1.7, United Kingdom), Beta (B.1.351, South Africa), Gamma (P.1, Brazil) and Delta (B.1.617.2, India) |
Paulo.R.S. Sanches, Ives Charlie-Silva, Helyson.L.B. Braz, Cintia Bittar, Marilia Calmon, Paula Rahal, Eduardo M. Cilli |
| 13 |
[GO] |
2021―Jul―05 |
Highlights from the virtual conference on retroviruses and opportunistic infections (CROI) 2021: SARS-CoV-2 pathogenesis, new data about antiretroviral treatments, HIV-associated comorbidities, pediatrics and pregnancy |
Christina K. Psomas, Laura J. Waters, Tristan Barber |
| 14 |
[GO] |
2021―Mai―19 |
Induction of Immune Response After SARS-CoV-2 mRNA BNT162b2 Vaccination in Healthcare Workers |
Salvatore Zaffina, Claudia Alteri, Alessandra Ruggiero, Nicola Cotugno, Maria Rosaria Vinci, Vincenzo Camisa, et al. (+19) Anna Paola Santoro, Rita Brugaletta, Gloria Deriu, Eva Piano Mortari, Ane Fernandez Salinas, Cristina Russo, Stefania Ranno, Luana Coltella, Luna Colagrossi, Ottavia Porzio, Andrea Onetti Muda, Massimiliano Raponi, Marta Ciofi degli Atti, Caterina Rizzo, Alberto Villani, Paolo Rossi, Paolo Palma, Rita Carsetti, Carlo Federico Perno |
| 15 |
[GO] |
2021―Mai―17 |
Impact of COVID-19 and ICU capacity on vaccination support: Evidence from a two-leg representative survey in the UK |
Géraldine Blanchard-Rohner, Bruno Caprettini, Dominic Rohner, Hans-Joaquim Voth |
| 16 |
[GO] |
2021―Mai―08 |
Prevention and control measures significantly curbed the SARS-CoV-2 and influenza epidemics in China |
Xiangsha Kong, Feng Liu, Haibo Wang, Ruifeng Yang, Dongbo Chen, Fengmin Lu, et al. (+2) Huiying Rao, Hongsong Chen |
| 17 |
[GO] |
2021―Feb―07 |
Interrupting antiretroviral therapy in HIV cure trials during COVID-19: Adaptation to low transmission settings. |
Jillian SY. Lau, Thomas A. Rasmussen, Sharon R. Lewin, Adam Ehm, Cipriano Martinez, Craig Burnett, James H. McMahon |
| 18 |
[GO] |
2021―Feb―06 |
Commentary Title: COVID-19 Research, Africa, and Global Health |
Tinkhani Mbichila, Grace Kumwenda, Ntando Yola, Quarraisha Abdool Karim, Tamar Tchelidze, Joseph Lau, et al. (+5) Stephanie Buchholz, Regine Lehnert, Jean-Michel Molina, Kenneth Mayer, Veronica Miller |
| 19 |
[GO] |
2020―Dez―06 |
HIV cure research in the time of COVID-19 - antiretroviral therapy treatment interruption trials: a discussion paper. |
S. Fidler, S. Lewin, S. Deeks, O.S. Sogaard, L. Vanderkerckhove, S. Collins, et al. (+4) D. Kelly, J. Singh, M. Caskey, J. Frater |
| 20 |
[GO] |
2020―Okt―15 |
Impact of COVID-19 on people with HIV: A Review |
Sandeep Prabhu, Selvamuthu Poongulali, Nagalingeswaran Kumarasamy |
| 21 |
[GO] |
2020―Jul―23 |
SARS coronavirus has antibody-dependent enhancement (ADE) effect through the autologous antibodies against envelope spikes on Fcγ receptor expressing cells |
Chun-Sheng Yeh, Jyh-Yuan Yang, Wu-Tse Liu, Jason C. Huang, Yi-Ming Arthur Chen, Sheng-Fan Wang |
| 22 |
[GO] |
2020―Jul―23 |
Human helicase DDX3 as target for broad-spectrum antivirals against pandemic and emerging viruses |
Annalaura Brai, Roberta Fazi, Cristina Tintori, Josè Estè, Roger Badia, Sandra Franco, et al. (+8) Miguel A. Martinez, Javier Martinez, Andreas Meyerhans, Francesco Saladini, Maurizio Zazzi, Anna Garbelli, Maurizio Botta, Giovanni Maga |
| 23 |
[GO] |
2020―Jul―10 |
Treatment strategies for Middle East respiratory syndrome coronavirus |
Kayvon Modjarrad |
| 24 |
[GO] |
2020―Jul―09 |
Climate change, socio-political changes and emerging pandemics |
Jean-Paul Gonzalez |
| 25 |
[GO] |
2020―Jul―02 |
Review of safety and minimum pricing of nitazoxanide for potential treatment of COVID-19 |
Toby Pepperrell, Victoria Pilkington, Andrew Owen, Junzheng Wang, Andrew M. Hill |
| 26 |
[GO] |
2020―Jul―02 |
Minimum costs to manufacture new treatments for COVID-19 |
Andrew Hill, Junzheng Wang, Jacob Levi, Katie Heath, Joseph Fortunak |
| 27 |
[GO] |
2020―Jul―02 |
A review of the safety of favipiravir - a potential treatment in the COVID-19 pandemic? |
Victoria Pilkington, Toby Pepperrell, Andrew Hill |
| 28 |
[GO] |
2020―Jul―02 |
Summary of the coronavirus disease 2019 (COVID-19) update from the 2020 Conference on Retroviruses and Opportunistic Infections, 8-11 March 2020, Boston, USA |
Christina K. Psomas, Sabine Kinloch |
|
